Proposed Collection; Comment Request; Generic Clearance to Conduct Voluntary Customer/Partner Surveys, 14137-14138 [E9-6934]
Download as PDF
14137
Federal Register / Vol. 74, No. 59 / Monday, March 30, 2009 / Notices
FDA’s burden estimate is based on
prior experience with surveys that are
similar to this proposed survey.
Dated: March 23, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–7002 Filed 3–27–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: Maternal and Child
Health Bureau Performance Measures
for Discretionary Grants (OMB No.
0915–0298): Revision
The Maternal and Child Health
Bureau (MCHB) intends to continue to
collect performance data for Special
Projects of Regional and National
Significance (SPRANS), Community
Integrated Service Systems (CISS), and
other grant programs administered by
MCHB.
The Health Resources and Services
Administration (HRSA) proposes to
continue using reporting requirements
for SPRANS projects, CISS projects, and
other grant programs administered by
MCHB, including national performance
measures, previously approved by OMB,
and in accordance with the
‘‘Government Performance and Results
Act (GPRA) of 1993’’ (Pub. L. 103–62).
This Act requires the establishment of
measurable goals for Federal programs
that can be reported as part of the
budgetary process, thus linking funding
decisions with performance.
Performance measures for MCHB
discretionary grants were initially
approved in January 2003. Approval
from OMB is being sought to continue
the use of these measures. Some of these
measures are specific to certain types of
programs, and will not apply to all
grantees. Furthermore, these measures
are based primarily on existing data,
thereby minimizing the response burden
consistent with program administration
and management needs. Through the
experience of utilizing these measures,
we are enhancing them to better reflect
program goals.
The estimated response burden is as
follows:
Form
Number of
respondents
Responses
per
respondent
Total
responses
Burden hours
per response
Total burden
hours
Grant Report ........................................................................
898
1
898
6
5,388
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA submission@omb.eop.gov
or by fax to 202–395–6974. Please direct
all correspondence to the ‘‘attention of
the desk officer for HRSA.’’
Dated: March 18, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E9–6910 Filed 3–27–09; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on PROD1PC70 with NOTICES
Proposed Collection; Comment
Request; Generic Clearance to
Conduct Voluntary Customer/Partner
Surveys
SUMMARY: In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995 to
provide opportunity for public comment
on proposed data collection projects, the
VerDate Nov<24>2008
18:33 Mar 27, 2009
Jkt 217001
National Library of Medicine (NLM), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: Generic
Clearance to Conduct Voluntary
Customer/Partner Surveys; Type of
Information Collection Request:
Extension of currently approved
collection [OMB No. 0925–0476,
expiration date 07/31/2009], Form
Number: NA; Need and Use of
Information Collection: Executive Order
12962 directed agencies that provide
significant services directly to the
public to survey customers to determine
the kind and quality of services they
want and their level of satisfaction with
existing services. Additionally, since
1994, the NLM has been a ‘‘Federal
Reinvention Laboratory’’ with a goal of
improving its methods of delivering
information to the public. An essential
strategy in accomplishing reinvention
goals is the ability to periodically
receive input and feedback from
customers about the design and quality
of the services they receive.
The NLM provides significant
services directly to the public including
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
health providers, researchers,
universities, other federal agencies, state
and local governments, and to others
through a range of mechanisms,
including publications, technical
assistance, and Web sites. These
services are primarily focused on health
and medical information dissemination
activities. The purpose of this
submission is to obtain OMB’s generic
approval to continue to conduct
satisfaction surveys of NLM’s
customers. The NLM will use the
information provided by individuals
and institutions to identify strengths
and weaknesses in current services and
to make improvements where feasible.
The ability to periodically survey NLM’s
customers is essential to continually
update and upgrade methods of
providing high quality service.
Frequency of Response: Annually or
biennially. Affected Public: Individuals
or households; businesses or other for
profit; State or local governments;
Federal agencies; non-profit institutions;
small businesses or organizations. Type
of Respondents: Organizations, medical
researchers, physicians and other health
care providers, librarians, students, and
the general public. The annual reporting
burden is as follows:
E:\FR\FM\30MRN1.SGM
30MRN1
14138
Federal Register / Vol. 74, No. 59 / Monday, March 30, 2009 / Notices
Types of respondents
Estimated
number of respondents
Estimated
number of responses per
respondent
Average burden hours per
response
Estimated total
annual burden
hours requested
Researchers, Physicians, Other Health Care Providers, Librarians, Students, General Public ...................................................................................
27,910
1
.129
3,607
The annualized cost to respondents
for each year of the generic clearance is
estimated to be $23,126. There are no
Capital Costs, Operating Costs, and/or
Maintenance Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: David Sharlip,
National Library of Medicine, Building
38A, Room B2N12, 8600 Rockville Pike,
Bethesda, MD 20894, or call non-toll
free number 301–402–9680 or E-mail
your request to sharlipd@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: March 23, 2009.
Betsy L. Humphreys, M.L.S.,
Deputy Director, National Library of
Medicine, National Institutes of Health.
[FR Doc. E9–6934 Filed 3–27–09; 8:45 am]
sroberts on PROD1PC70 with NOTICES
BILLING CODE 4140–01–P
VerDate Nov<24>2008
18:33 Mar 27, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
Federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Method of Making a Vaccine
Description of Technology: Current
invention describes the methods to
prepare vaccines, and to use such
vaccines in the vaccination and
treatment of human disease, e.g., the
human immunodeficiency virus (HIV)
infections and cancer. More specifically,
the present invention provides a vaccine
and method for making same which is
effective to elicit a desired antibody
against a target antigen comprising a
primary immunogen and a secondary
immunogen, wherein the primary
immunogen is effective to elicit B cell
receptors (BCRs) that are on the
maturational pathway of the desired
antibody and have an intermediate
degree of somatic mutational diversity,
and the secondary immunogen
comprises an epitope of the desired
target antibody and is effective to
further diversify the BCRs sufficient to
form mature BCRs having the identical
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
or substantially identical sequence as
the desired antibody.
Applications: Treatment and
prevention of HIV infection.
Advantages: Novel methods to design
vaccines for HIV treatment and
prevention; May also be used for
designing vaccines for cancer treatment.
Development Status: In vitro data
available.
Market: HIV therapeutics and
preventatives.
Inventor: Dimiter S. Dimitrov (NCI).
Publications:
1. MY Zhang, Y Shu, S Phogat, X
Xiao, F Cham, P Bouma, A Choudhary,
YR Feng, I Sanz, S Rybak, CC Broder,
GV Quinnan, T Evans, DS Dimitrov.
Broadly cross-reactive HIV neutralizing
human monoclonal antibody Fab
selected by sequential antigen panning
of a phage display library. J Immunol
Methods. 2003 Dec;283(1–2):17–25.
2. MY Zhang, X Xiao, IA Sidorov, V
Choudhry, F Cham, PF Zhang, P Bouma,
M Zwick, A Choudhary, DC Montefiori,
CC Broder, DR Burton, GV Quinnan Jr,
DS Dimitrov. Identification and
characterization of a new cross-reactive
human immunodeficiency virus type 1neutralizing human monoclonal
antibody. J Virol. 2004 Sep;78(17):9233–
9242.
3. Z Zhu, AS Dimitrov, KN Bossart, G
Crameri, KA Bishop, V Choudhry, BA
Mungall, YR Feng, A Choudhary, MY
Zhang, Y Feng, LF Wang, X Xiao, BT
Eaton, CC Broder, DS Dimitrov. Potent
neutralization of Hendra and Nipah
viruses by human monoclonal
antibodies. J Virol. 2006 Jan;80(2):891–
899.
4. MY Zhang, V Choudhry, IA
Sidorov, V Tenev, BK Vu, A Choudhary,
H Lu, GM Stiegler, HW Katinger, S
Jiang, CC Broder, DS Dimitrov. Selection
of a novel gp41-specific HIV-l
neutralizing human antibody by
competitive antigen panning. J Immunol
Methods. 2006 Dec 20;317(1–2):21–30.
5. V Choudhry, MY Zhang, IA
Sidorov, JM Louis, I Harris, AS
Dimitrov, P Bouma, F Cham, A
Choudhary, SM Rybak, T Fouts, DA
Montefiori, CC Broder, GV Quinnan Jr,
DS Dimitrov. Cross-reactive HIV–1
neutralizing monoclonal antibodies
selected by screening of an immune
human phage library against an
envelope glycoprotein (gpI40) isolated
E:\FR\FM\30MRN1.SGM
30MRN1
Agencies
[Federal Register Volume 74, Number 59 (Monday, March 30, 2009)]
[Notices]
[Pages 14137-14138]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6934]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; Generic Clearance to
Conduct Voluntary Customer/Partner Surveys
SUMMARY: In compliance with the requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995 to provide opportunity for public
comment on proposed data collection projects, the National Library of
Medicine (NLM), the National Institutes of Health (NIH) will publish
periodic summaries of proposed projects to be submitted to the Office
of Management and Budget (OMB) for review and approval.
Proposed Collection: Title: Generic Clearance to Conduct Voluntary
Customer/Partner Surveys; Type of Information Collection Request:
Extension of currently approved collection [OMB No. 0925-0476,
expiration date 07/31/2009], Form Number: NA; Need and Use of
Information Collection: Executive Order 12962 directed agencies that
provide significant services directly to the public to survey customers
to determine the kind and quality of services they want and their level
of satisfaction with existing services. Additionally, since 1994, the
NLM has been a ``Federal Reinvention Laboratory'' with a goal of
improving its methods of delivering information to the public. An
essential strategy in accomplishing reinvention goals is the ability to
periodically receive input and feedback from customers about the design
and quality of the services they receive.
The NLM provides significant services directly to the public
including health providers, researchers, universities, other federal
agencies, state and local governments, and to others through a range of
mechanisms, including publications, technical assistance, and Web
sites. These services are primarily focused on health and medical
information dissemination activities. The purpose of this submission is
to obtain OMB's generic approval to continue to conduct satisfaction
surveys of NLM's customers. The NLM will use the information provided
by individuals and institutions to identify strengths and weaknesses in
current services and to make improvements where feasible. The ability
to periodically survey NLM's customers is essential to continually
update and upgrade methods of providing high quality service. Frequency
of Response: Annually or biennially. Affected Public: Individuals or
households; businesses or other for profit; State or local governments;
Federal agencies; non-profit institutions; small businesses or
organizations. Type of Respondents: Organizations, medical researchers,
physicians and other health care providers, librarians, students, and
the general public. The annual reporting burden is as follows:
[[Page 14138]]
----------------------------------------------------------------------------------------------------------------
Estimated
Estimated number of Average burden Estimated total
Types of respondents number of responses per hours per annual burden
respondents respondent response hours requested
----------------------------------------------------------------------------------------------------------------
Researchers, Physicians, Other Health Care 27,910 1 .129 3,607
Providers, Librarians, Students, General
Public.....................................
----------------------------------------------------------------------------------------------------------------
The annualized cost to respondents for each year of the generic
clearance is estimated to be $23,126. There are no Capital Costs,
Operating Costs, and/or Maintenance Costs to report.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: David Sharlip, National Library of Medicine,
Building 38A, Room B2N12, 8600 Rockville Pike, Bethesda, MD 20894, or
call non-toll free number 301-402-9680 or E-mail your request to
sharlipd@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: March 23, 2009.
Betsy L. Humphreys, M.L.S.,
Deputy Director, National Library of Medicine, National Institutes of
Health.
[FR Doc. E9-6934 Filed 3-27-09; 8:45 am]
BILLING CODE 4140-01-P